9820 — MT Genex Income Statement
0.000.00%
Last trade - 00:00
- ¥3bn
- ¥1bn
- ¥3bn
- 92
- 80
- 56
- 93
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
Standards: | JAS | JAS | JAS | JAS | JAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2,477 | 3,265 | 3,010 | 2,970 | 3,263 |
Cost of Revenue | |||||
Gross Profit | 659 | 896 | 763 | 805 | 849 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 2,165 | 2,746 | 2,699 | 2,642 | 2,898 |
Operating Profit | 311 | 518 | 310 | 329 | 365 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 323 | 528 | 328 | 342 | 383 |
Provision for Income Taxes | |||||
Net Income After Taxes | 215 | 346 | 227 | 213 | 242 |
Net Income Before Extraordinary Items | |||||
Net Income | 215 | 346 | 227 | 213 | 242 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 215 | 346 | 227 | 213 | 242 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 200 | 322 | 224 | 230 | 257 |
Dividends per Share |